Printer Friendly

Effects of PPR vaccine on goat haematology in Tangail district of Bangladesh.


Goat is an economically valuable animal for the poor people of Bangladesh. At present the approximate number of goats in our country is 33.5 million (Samad, 2001). The local indigenous goat breed "Black Bengal" is highly prolific and a good survivor (Devandra, 1979). However, among many constraints of goat production in our country PPR (Peste des Petits Ruminants) is the most dangerous one (Kamaruddin and Islam, 2005). Outbreaks of PPR are common in South-East Asia including Bangladesh (Taylor et al., 1990). The prevalence of this disease is higher in young animals (65.58%) than in adults (45.92%) (Rajeswari et al., 2000). Prevalence of PPR is higher in Black Bengal goats (67-74%) than in Jamunapari goats (32.76%) (Mondaletal., 1995).

Hematological tests are widely used for the diagnosis of various animal diseases (Tibbo et al., 2004) that help in determining the nature of disease and the response of the defense mechanism of the patient (Schalm et al., 1975). Various workers have reported on the treatment, vaccine development and diagnosis of PPR of goats. But there is very limited study on the hematological values of animals vaccinated with different doses of PPR vaccine. Therefore, the present study was undertaken to observe the blood parameters of goats after vaccination and after challenge with field virus.

Materials and Methods

Study area and animal management. The study was conducted during the period May 26, 2007 to July 2, 2007 at Modhupur of Tangail district, Bangladesh. A total of 18 female, apparently healthy goats of the same age (4-6 months) were purchased from different places of Tangail district. The goats bought from each market were kept in separate houses and observed for at least 15 days. All the goats were identified by hanging a labeled tag around their neck. The feeding program was mainly intensive, where all the goats were supplied with ample amount of water, enough grass and leaves and 100g concentrate/goat/day. To avoid the effect of parasitism on normal hematological parameters, all the goats were dewormed with a potentiated anthelmintic containing levamisole and triclabendazole.

Study design and data collection. Goats were divided into six groups. Sampling was repeated for 4 times such as seven days pre vaccination, seven days post vaccination, 14 days post vaccination and seven days after challenge with PPR virus.

As the restraining of animals affects the hematological values, blood was collected from the animals at rest, with minimum excitement or disturbance (Jain, 1993). This was done by allowing the animals to rest for at least 4 min of an adaptation time before sampling. The sampling time was fixed at 9.00 a.m. to avoid the effect of diurnal variation (Tibbo et al., 2004) and sampling following the order of same serial number each time.

5 mL of blood was drawn from the external jugular vein by venipuncture of the 18 goats. The blood samples from each goat were taken into a dry, clean, vacuum and labeled tube containing anticoagulants.

Method of vaccination. One hundred dose vial of freeze-dried PPR vaccine (LRI, Mohakhali) was reconstituted in 100 mL of sterile refrigerated solution supplied with the vaccine. The reconstituted vaccine was injected into a goat subcutaneously in the neck region, with a sterile needle following all the instructions of the manufacturer.

Laboratory analysis. Packed Cell Volume (PCV) and Hemoglobin estimation (Hb) were determined by microhaematocrit and cyanomethemoglobin methods, respectively (Ghai, 1999). Total Leukocyte Count (TLC) was performed according to the method described by Schalm et al. (1975). ESR (Erythrocyte Sedimentation Rate) and TEC (Total Erythrocyte Count) were determined following the procedures described by Ghai (1999).

Challenge with virus. After 14 days of post vaccination all the goats were challenged with PPR virus collected from research Institute. One hundred dose vial of freeze-dried PPR virus was reconstituted in 100 mL of sterile refrigerated solution. 3 mL of the reconstituted virus was injected into a goat subcutaneously in the neck region, with a sterile needle.

Statistical analysis. Repeated Measures Analysis of Covariance (RMANCOVA) in Completely Randomized Design (CRD) was performed to investigate the effect of different doses of vaccine on various blood parameters of Black Bengal goats (Zar, 2002). Body weight of the goat was incorporated in the analysis as the covariate for adjusting the effects of the unequal body weights on the hematological parameters viz., TEC, TLC, Hb, ESR and PCV (Table 1). In the analysis, the dependent variables were these parameters. The hematological parameters were considered as the within subjects factors because they were repeatedly measured on the experimental goats. Vaccine (independent variable) was treated as the between subjects factor. The sphericity test was done to identify which one was the most appropriate: the MANOVA or the univariate test. The sphericity assumption states that the variance of the difference scores in a within subjects design ([S.sub.d.sup.2] in a paired t-test) are equal across all the groups. That is, the variances of each of these sets of difference scores are not statistically different from one another. Mauchly's test of sphericity was performed in this study (Table 2). According to this test, if the significant level of any parameter is greater than 0.05, the sphericity assumption is met and hence univariate test results can be accepted for repeated measures ANOVA. In Mauchly's test of sphericity, the value of epsilon should be greater than 0.75 (1.00 indicate perfect sphericity). Where the value of epsilon was less than 0.75, the results of the Huynh-Feldt corrections of univariate tests were used (Max and Onghena, 1999). All of the multiple comparisons of the various parameters were performed by least significant difference (lsd) test after adjustment for unequal body weights of the experimental goats.

Results and Discussion

Effect on TEC. The within-subjects test indicates that there was a significant (P<0.01) time effect on TEC of goats and TEC significantly (P<0.05) decreased over time at a cubic pattern (Table 3-4). The 3rd and 4th observations exhibited a significant (P<0.05) reduction in the mean values of TEC with respect to 1st and 2nd observations (Table 5). The interaction effect of vaccine on TEC over time was significant (P<0.01) and it acted quadratically (Table 3 and 4). According to Devireddy et al. (1999) PPR virus contains a protein which causes lysis of erythrocytes. It might be occurred due to the cause that the values of TEC decreased after vaccination and after challenge with the virus as the PPR vaccine contained live attenuated viruses. Besides, the PPR antigen might attach to erythrocyte membrane making the cells more susceptible to phagocytosis by macrophages resulting in decreased number of RBC count (Aikhuomobhogbe and Orheruata, 2006).

Effect on TLC. Pairwise comparison of TLC for different doses of vaccine has been shown in Table 6. The between-subjects effects of vaccine on TLC was significant (P<0.01) (Table 7). It is evident from the Table 1 and 7 that there existed a significant (P<0.01) difference among the effects of different doses of vaccine and double dose of vaccine reduced TLC to a significant (P<0.05) extent with respect to other two doses. The reduction in leukocyte numbers occurred possibly due to their response to vaccination (Aikhuomobhogbe and Oreruata, 2006). This also might be due to the immunosuppressive effect of the PPR virus (Haroun et al., 2005; Heaney et al., 2002) of the vaccine. This finding is similar to that of Rajak et al. (2005).

Effect on Hb estimation. The within-subjects test implies that there existed a significant (P<0.05) time effect on Hb concentration of goats (Table 3). Table 5 demonstrates that the reduction of Hb concentration at each of 7 days duration was significant (P<0.05). Hb concentration declined cubicly over time (Table 4). Hb concentration decreased after vaccination and after challenge with virus. According to Benjamin (1978) hemoglobin concentration might be decreased if there was reduction in the size of RBC rather than number. But in this case it can be hypothesized that the hemoglobin concentration decreased due to the reduction in the number of RBC. In another way it can be said that as TEC decreased, the Hb concentration decreased as well.

Effect on ESR. The within-subjects effects on ESR revealed that time had a significant (P<0.001) effect on ESR (Table 3). Time influenced ESR in a quadratic pattern (Table 3-4). ESR increased as the time duration increased after vaccination. The increment was recorded as significant (P<0.05) in 3rd and 4th observations (Table 5). But ESR increased to a great extent in the 4th observation (Table 5). In this study, no prevaccination sedimentation of erythrocytes was observed. But after vaccination and after challenge with the vaccine settling of RBC was observed. The virus caused hemolysis of RBC (Devireddy et al., 1999) which led to an increased ESR. According to Jain (1986), ESR increases in inflammatory conditions and in acute generalized infection, with change in concentration of various proteins in blood. It can also be stated that increased ESR was due to the decreased TEC. This finding was similar with that of Hayat et al. (1999).

Effect on PCV. It could be inferred from the test of within-subjects effects that there existed a significant (P<0.001) time effect on the values of PCV of goats and PCV value decreased over time following a linear trend pattern (Table 3-4). Table 5 reveals that PCV value reduced significantly (P<0.01) at each observation. The PCV values reduced at each observation that is after starting of vaccination. The attachment of PPR antigen to erythrocyte membrane rendered the cells more susceptible to phagocytosis by macrophages, thus resulting in decreased PCV values (Aikhuomobhogbe and Oreruata, 2006).

In conclusion, results of this study reveal that the PPR virus and PPR vaccine affected the goat haematology. Therefore, it is necessary to vaccinate the goats in order to protect them from the disease.


Aikhuomobhogbe, P.U., Orheruata, A.M. 2006. Haematological and blood biochemical indices of West African Dwarf goats vaccinated against Pestes des Petit ruminants (PPR). African Journal of Biotechnology, 5: 743-748.

Benjamin, M.M. 1978. Outline of Veterinary Clinical Pathology. 2nd edition, pp. 35-105, The Iowa State University Press, Iowa, USA.

Devandra, C. 1979. Goat production in the Asian region: Current status, available genetic resources and potential prospects. In: International Seminar on the Development of Goats in Asia, Karnal, India.

Devireddy, L.R., Raghavan, R., Ramachandran, S., Shaila, M.S. 1999. The fusion protein of peste des petits ruminants virus is a hemolysin. Arch Viral, 144: 1241-1247.

Ghai, C.L. 1999. A Text Book of Practical Physiology. 5th edition, pp. 24-77, Jaypee Brothers Medical Publishers, New Delhi, India.

Haroun, M., Hajer, I.E., Mukhtar, M.M., Barrett, T. 2005. Protection against rinderpest disease: a vaccinated and challenge study in Angus calves. Journal of Animal Veterinary Adv, 4: 1025-1028.

Hayat, C.H., Khalid, M., Iqbal, Z., Akhtar, M. 1999. Hematological and biochemical disturbances associated with Toxocara vitulorum infection in buffalo calves. International Journal of Agriuculture Biology, 1: 247-249.

Heaney, J., Barrett, T., Cosby, S.L. 2002. Inhibition of in vitro leukocyte proliferation by morbilliviruses. Journal of Virology, 76: 3579-3584.

Jain, N.C. 1993. Essentials of Veterinary Hematology. Lea & Febiger, Philadelphia, USA.

Jain, N.C. 1986. Schalm's Veterinary Hematology, 4th edition, 417 pp., Lea & Febiger, Philadelphia, USA.

Kamaruddin, K.M., Islam, M.R. 2005. Transboundary diseases in Bangladesh: PPR and rinderpest. In: Proceedings of 11th BSVER (Bangladesh Society of Veterinary Education and Research) Annual Scientific Conference, pp. 19-20, Bangladesh Agricultural University, Mymensingh, Bangladesh.

Max, L., Onghena, P. 1999. Some issues in the statistical analysis of completely randomized and repeated measures designs for speech, language, and hearing research. Journal of Speech-up language and Hearing Research, 42: 261-270.

Mondal, A.K., Chottopadhuay, A.P., Sarkar, S.D., Saha, G.R., Bhowmik, M.K. 1995. Report on epizootological and clinico-pathological observation on peste des petits ruminants in west Bengal. Indian Journal of Animal Health, 64: 261.

Rajak, K.K., Sreenivasa, B.P., Hosamani, M., Singh, R.P., Singh, S.K., Singh, R.K., Bandyopadhyay, S.K. 2005. Experimental studies on immunosuppressive effects of peste des petits ruminants (PPR) virus in goats. Comparative Immunology, Microbiology & Infection Diseases, 28: 287-296.

Rajeswari, K.B., Sastry, P.R., Rao, M.R. 2000. PPR pest of small ruminants virus in small ruminants in Andhra Pradesh. Indian Veterinary Journal, 77: 373-375.

Samad, M.A. 2001. Pashu Palon O Chikitsavidya. 2nd edition, pp. 3, LEPNo.09. Bangladesh Agricultural University Campus, Mymensingh, Bangladesh.

Schalm, O.W., Jain, N.C., Carroll, E.J. 1975. Veterinary Hematology. 3rd edition, 807 pp., Lea & Febiger, Philadelphia, USA.

Taylor, W.P., Al-Busaidy, S., Barrett, T. 1990. The epidemiology of PPR in the sultanate of Oman. Veterinary Microbiology, 22: 341-352.

Tibbo, M., Jibril, Y., Woldemeskel, M., Dawo, F., Aragaw, K., Rege, J.E.O. 2004. Factors affecting hematological profiles in three Ethiopian indigenous goat breeds. International Journal of Applied Research of Veterinary Medicine, 2: 297-309.

Zar, J.H. 2002. Biostatistical Analysis. 4th edition, pp. 255-270, Pearson Education (Singapore) Pvt. Ltd., Singapore.

Ausraful Islam (a) *, Shankar Majumder (b), Amitav Singha (a) and Muhammad Kamrul Islam (c)

(a) Mennonite Central Comittee, Bangladesh

(b) Department of Agricultural Statistics, Faculty of Agricultural Economics and Rural Sociology, Bangladesh Agricultural University, Mymensingh-2202, Bangladesh

(c) Department of Physiology, Faculty of Veterinary Science, Bangladesh Agricultural University, Mymensingh-2202, Bangladesh

(d) GPO Box 128, Dhaka--1000, Bangladesh

(received December 28, 2010; revised September 14, 2011; accepted September 25, 2011)

* Author for correspondence; E-mail:

(d) Permanent address
Table 1. The mean value * (adjusted for unequal body
weights) with its standard error of TEC, TLC, Hb, ESR
and PCV at different doses of vaccine

Parameters   Single dose                  Double dose

TEC          8.87 [+ or -] 0.121          9.06 [+ or -] 0.118
TLC          1005.63 (a) [+ or -] 8.692   974.17 (b) [+ or -] 8.533
Hb           8.62 [+ or -] 0.113          8.71 [+ or -] 0.111
ESR          4.97 [+ or -] 0.180          5.18 [+ or -] 0.176
PCV          20.47 [+ or -] 0.506         20.88 [+ or -] 0.497

Parameters   Single dose boosting
             after 7 days

TEC          9.03 [+ or -] 0.119
TLC          1017.29a [+ or -] 8.593
Hb           8.60 [+ or -] 0.112
ESR          5.23 [+ or -] 0.178
PCV          21.01 [+ or -] 0.501

* Mean values were compared by Least Significant Difference
(LSD) test. Mean values having different superscripts
differed significantly at 1% level of probability.

Table 2. Mauchly's test of sphericity

Parameters   Within    Mauchly's W   Approx.   df
             subject   [Chi.sup.2]

TEC          Time      0.603         6.425     5
TLC          Time      0.593         6.653     5
Hb           Time      0.672         5.056     5
ESR          Time      0.573         7.081     5
PCV          Time      0.814         2.614     5

Parameters   Sig          Epsilon

                     Greenhouse   Huynh
                     -Geisser     -Feldt

TEC          0.268   0.759        1
TLC          0.249   0.729        1
Hb           0.410   0.820        1
ESR          0.126   0.795        1
PCV          0.76    0.891        1

Table 3. Tests of within-subjects effects on the hematological
parameters TEC, TLC, Hb, ESR and PCV

Source                              F-values

                            TEC       TLC       Hb

Time          Sphericity    9.17 **   --        6.041 **

              Huynh-Feldt   --        2.879 *   --

Time x Body   Sphericity    1.828     3.780 *   3.599 *
weight        assumed

Time x        Sphericity    3.156 *   2.468 *   0.536
Vaccine       assumed

Source                            F-values

                            ESR         PCV

Time          Sphericity    43.409 **   14.069 **

              Huynh-Feldt   --          --

Time x Body   Sphericity    43.409 **   1.259
weight        assumed

Time x        Sphericity    0.727       1.567
Vaccine       assumed

** indicates significant difference at 1% level of probability;
* indicates significant difference at 5% level of probability

Table 4. Tests of within-subjects contrasts for TEC,
Hb, ESR and PCV (a)

Parameter   Source               TIME        F

TEC         Time                 Cubic       5.662 *

            Time x Vaccine       Quadratic   4.237 *

Hb          Time                 Cubic       8.495 *

            Time x Body weight   Cubic       9.350 *

ESR         Time                 Quadratic   31.686 **

PCV         Time                 Linear      50.651 **

** indicates significant at 1% level of probability;
* indicates significant at 5% level of probability;
(a) Other parameters were not mentioned because of
insignificant effect\patterns on them.

Table 5. Pairwise comparisons (b) of TEC, TLC, Hb, ESR and PCV at
different observations

(I)    (J)        Mean difference (a) (I-J) for the parameters
Time   Time

              TEC        TLC         Hb         ESR         PCV

1      2      0.022      -34.722 *   0.311 *    -0.333      4.667 *
       3      1.588 *    12.500      0.867 *    -1.528 *    6.889 *
       4      2.434 *    -75.000 *   2.044 *    -18.639 *   25.083 *

2      1      -0.022     34.722 *    -0.311 *   0.333       -4.667 *
       3      1.566 *    47.222 *    0.556 *    -1.194 *    2.222 *
       4      2.413 *    -40.278 *   1.733 *    -18.306 *   20.417 *

3      1      -1.588 *   -12.500     -0.867 *   1.528 *     -6.889 *
       2      -1.566 *   -47.222 *   -0.556 *   1.194 *     -2.222 *
       4      0.847 *    -87.500 *   1.178 *    -17.111 *   18.194 *

4      1      -2.434 *   75.000 *    -2.044 *   18.639 *    -25.083 *
       2      -2.413 *   40.278 *    -1.733 *   18.306 *    -20.417 *
       3      -0.847 *   87.500 *    -1.178 *   17.111 *    -18.194 *

(a) The mean difference is significant at 5% level of probability;

(b) Multiple comparisons: LSD test.

Table 6. Pairwise comparisons (b) of TLC for different doses
of vaccine

Vaccine (I)   Vaccine (J)    Mean             Standard   P-value
                             difference (a)   error
                             (I-J)            (SE)

Single dose   Double dose    31.466 *         12.265     .022

              Boosting       -11.657          12.390     0.363
              after 7 days

Double dose   Single dose    -31.466 *        12.265     0.022

              Boosting       -43.123 *        12.053     0.003
              after 7 days

Boosting      Single dose    11.657           12.390     0.363
after 7
days          Double dose    43.123 *         12.053     0.003

Vaccine (I)   Vaccine (J)    95% Confidence interval for

                             Lower bound   Upper bound

Single dose   Double dose    5.161         57.772

              Boosting       -38.231       14.918
              after 7 days

Double dose   Single dose    -57.772       -5.161

              Boosting       -68.974       -17.272
              after 7 days

Boosting      Single dose    -14.918       38.231
after 7
days          Double dose    17.272        68.974

Body weights were adjusted for multiple comparisons: LSD;
(a) The mean difference is significant at 5% level of probability.
(b) Pairwise comparisons of the other parameters were not
presented because of their insignificant mean differences at
different doses of vaccine.

Table 7. Tests of between-subjects effects on TEC,
TLC, Hb, ESR and PCV (adjusting unequal body

Source    F-values with the levels of significance
          for the parameters

          TEC       TLC       Hb        ESR       PCV

Vaccine   0.247     6.865     0.283     0.577     0.375
          (0.737)   (0.008)   (0.758)   (0.575)   (0.694)
COPYRIGHT 2012 Pakistan Council of Scientific and Industrial Research
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Author:Islam, Ausraful; Majumder, Shankar; Singha, Amitav; Islam, Muhammad Kamrul
Publication:Pakistan Journal of Scientific and Industrial Research Series B: Biological Sciences
Article Type:Report
Geographic Code:9BANG
Date:Mar 1, 2012
Previous Article:Anti irritant activity of extract from the aerial parts of Echinops echinatus compositae.
Next Article:Forensic entomology: when puparia of insect stages is the only link to cause.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters